Broad market headline — check whether risk appetite shifts.
Watch: REGN · EPS · .SPX · .FTSE
← Markets · United States hub · Watchlists · Compare · News
REGN
Regeneron is a healthcare name tracked on StockWatch with delayed quotes, charts, and related news. Home market: United States.
Sign in to jump from your saved watchlists.
$667.17
+11.16+1.70%
CNBCJul 27, 2026, 8:00 PM
Delayed market data from CNBC. Not investment advice.
About Regeneron
HealthcareUnited States · United States market hub
Regeneron is a healthcare name tracked on StockWatch with delayed quotes, charts, and related news. Home market: United States.
Key statistics
Delayed fundamentals for REGN · Finnhub.
- Market cap
- $70.17B
- P/E (TTM)
- 15.58
- EPS (TTM)
- $41.0277
- Div. yield
- 57.32%
- 52-week range
- $541.00 – $821.11
- Volume
- —
- Avg volume
- 688.3K
Price history
OHLC candles for REGN · 3mo · 1day · Twelve Data · delayed · EMA / RSI
News for REGN
See all newsDirect mentions, stories that impact this name, and related market themes — with Impact Analysis on each headline.
- REGN DEADLINE: Levi & Korsinsky Reminds Regeneron
- Curious about Regeneron (REGN) Q2 Performance? Explore Wall Street Estimates for Key Metrics
- $REGN Lawsuit Notice: BFA Law Reminds Regeneron Investors
- 14,700 Shares in Regeneron Pharmaceuticals, Inc. $REGN Acquired by Orbimed Advisors LLC
- 3,883 Shares in Regeneron Pharmaceuticals, Inc. $REGN Purchased by Lombard Odier Asset Management Switzerland SA
- Regeneron Pharmaceuticals, Inc. $REGN Shares Acquired by Family Manage LLC
- Regeneron Pharmaceuticals, Inc. $REGN Shares Sold by Healthcare of Ontario Pension Plan Trust Fund